Found 65 matching trials
Multicenter Registry of Pediatric Lupus Nephritis in China N/A This study is designed to evaluate the efficacy and safety of the current t...
Show More Location
The Second Xiangya Hospital, Central South University
Learn More & Join Trial
The Iguratimod Effect on Lupus Nephritis (IGeLU) PHASE2 This study is a 52-week, randomized, open, active-controlled trial of patie...
Show More Learn More & Join Trial
PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure PHASE2 Extracorporeal photopheresis (ECP) is an immunomodulatory therapy in which ...
Show More Location
Multiple Locations
Learn More & Join Trial
Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM) N/A Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-Cytokine Therapy for Vasculitis PHASE2 The purpose of this study is to determine whether Infliximab (monoclonal an...
Show More Location
University Hospitals Birmingham NHS Foundation Trust
Learn More & Join Trial
Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus PHASE2 Pemphigus is a severe autoimmune blistering disease mediated by circulating...
Show More Location
Department of Dermatology, University of Luebeck
Learn More & Join Trial
LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis PHASE2 An open-label, multi-center, prospective, randomized study to evaluate the ...
Show More Location
Mayo Clinic - Phoenix
Learn More & Join Trial
Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial PHASE4 The gold-standard treatment of Autoimmune hepatitis (AIH), with prednisone ...
Show More Location
Multiple Locations
Learn More & Join Trial
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE) PHASE1 Hypothesis: A reason for repeated disappointing outcomes of clinical trials...
Show More Location
Oklahoma Medical Research Foundation
Learn More & Join Trial
Immune Thrombocytopenia Management in Adults PHASE4 Immune thrombocytopenia treatment has evolved recently. However, none of tr...
Show More Learn More & Join Trial